| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/29/2010 | WO2010046588A1 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates |
| 04/29/2010 | WO2010046462A1 Antibiotic synergism |
| 04/29/2010 | WO2010046461A2 Treatment of intracellular bacterial infections |
| 04/29/2010 | WO2010046357A1 Amylin derivatives |
| 04/29/2010 | WO2010046321A1 Nutritional composition with anti-regurgitation properties |
| 04/29/2010 | WO2010046316A2 A topical composition |
| 04/29/2010 | WO2010046298A2 Improved peptide availability |
| 04/29/2010 | WO2010046297A1 Improving peptide availabilty |
| 04/29/2010 | WO2010046097A1 Cancer treatments with radiation and immunocytokines |
| 04/29/2010 | WO2010045723A1 Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent |
| 04/29/2010 | WO2010028089A3 Agents and methods for treatment of pain |
| 04/29/2010 | WO2010027405A3 Formulations of gc-c receptor agonist polypeptides |
| 04/29/2010 | WO2010019717A3 Combination therapy of hiv fusion/entry inhibitors targeting gp41 |
| 04/29/2010 | WO2010017248A3 Sting (stimulator of interferon genes), a regulator of innate immune responses |
| 04/29/2010 | WO2010017198A3 Fgfr extracellular domain acidic region muteins |
| 04/29/2010 | WO2010011994A3 Polypeptides and uses thereof |
| 04/29/2010 | WO2010011947A3 AMYLOID ß PEPTIDE ANALOGUES, OLIGOMERS THEREOF, PROCESSES FOR PREPARING AND COMPOSITIONS COMPRISING SAID ANALOGUES OR OLIGOMERS, AND THEIR USES |
| 04/29/2010 | WO2010011693A3 Proteins containing expanded polyglutamine tracts induce mitochondrial fragmentation by disrupting mitochondrial fusion |
| 04/29/2010 | WO2010011597A3 Treatment of obesity and related disorders |
| 04/29/2010 | WO2010009227A3 Recombinant pokeweed antiviral proteins, compositions and methods related thereto |
| 04/29/2010 | WO2010007551A3 Method for the production of tenocytes in vitro from mesenchymal stem cells |
| 04/29/2010 | WO2010006267A3 Cyclic tetrapeptides |
| 04/29/2010 | WO2010005533A3 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa |
| 04/29/2010 | WO2010002283A3 New insulin analogues of prolonged activity |
| 04/29/2010 | WO2009152493A9 Use of apolipoproteins to decrease inflammation |
| 04/29/2010 | WO2009143483A3 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION |
| 04/29/2010 | WO2009136033A3 Cosmetic use of annexin ii-type proteins for treating dryness of the skin |
| 04/29/2010 | WO2009135939A3 Pm02734 for use in the treatment of ewing' s sarcoma, osteosarcoma, rhabdomyosarcoma and medulloblastoma |
| 04/29/2010 | WO2009133099A3 Insulin precursors for oral diabetes treatment |
| 04/29/2010 | WO2009131553A3 Methods of altering bone growth by administration of sost or wise antagonist or agonist |
| 04/29/2010 | WO2009115782A3 Compounds derived from muramyldipeptide |
| 04/29/2010 | WO2009109156A3 Novel antimicrobial peptides and their application |
| 04/29/2010 | WO2009081368A3 Cosmetic use desmoglein i-type proteins |
| 04/29/2010 | WO2009034453A4 Method for the immobilization of bioactive molecules within a polymeric substrate resistant to the stomach acids as oral drug delivery system |
| 04/29/2010 | WO2009010270A8 Purification of pegylated polypeptides |
| 04/29/2010 | US20100105914 Caspase inhibitors and uses thereof |
| 04/29/2010 | US20100105878 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor |
| 04/29/2010 | US20100105870 Method Of Complexing A Protein By The Use Of A Dispersed System And Proteins Thereof |
| 04/29/2010 | US20100105867 Process for producing osteocalcin-containing extract |
| 04/29/2010 | US20100105781 Abuse resistant lysine amphetamine compounds |
| 04/29/2010 | US20100105632 Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 04/29/2010 | US20100105629 N-Substituted Peptidomimetic Inhibitors of Dipeptidylpeptidase IV |
| 04/29/2010 | US20100105627 Pharmaceutical compositions and related methods of delivery |
| 04/29/2010 | US20100105626 Novel Analogues of Antimicrobial and Anticancer Peptide Synthesized and Produced from Gaegurin 5 |
| 04/29/2010 | US20100105625 Product and Methods for Diagnosis and Therapy for Cardiac and Skeletal Muscle Disorders |
| 04/29/2010 | US20100105624 Calcitonin drug-oligomer conjugates, and uses thereof |
| 04/29/2010 | US20100105623 Schizophrenia-related isoform of kcnh2 and development of antipsychotic drugs |
| 04/29/2010 | US20100105622 Protein Product for Treatment of Infectious Diseases and Related Inflammatory Processes |
| 04/29/2010 | US20100105621 Therapies for acute renal failure |
| 04/29/2010 | US20100105620 Polypeptides that bind Trail-R1 and Trail-R2 |
| 04/29/2010 | US20100105619 Cysteine-containing peptides having antioxidant properties |
| 04/29/2010 | US20100105618 Non-Natural Recombinant Gelatins with Enhanced Functionality |
| 04/29/2010 | US20100105617 C-Terminal Attachment of Two Chemical Groups to Peptides |
| 04/29/2010 | US20100105616 Polyethylene glycol-g-csf conjugate |
| 04/29/2010 | US20100105615 Nutritional Composition To Promote Healthy Development And Growth |
| 04/29/2010 | US20100105614 Ultra low dose doxepin and methods of using the same to treat sleep disorders |
| 04/29/2010 | US20100105613 Therapeutic agent for occlusive peripheral vascular disease, and use thereof |
| 04/29/2010 | US20100105612 Agent containing fused protein of soluble rankl with epitope tag |
| 04/29/2010 | US20100105611 Method of treating respiratory disorders |
| 04/29/2010 | US20100105610 Methods of Inhibiting Tumor Cell Aggressiveness Using the Microenvironment of Human Embryonic Stem Cells |
| 04/29/2010 | US20100105609 Processes for Preparing Eptifibatide |
| 04/29/2010 | US20100105608 Peptides and methods using same for diagnosis and treatment of amyloid-associated disease |
| 04/29/2010 | US20100105607 Novel semi-synthetic glycopeptides as antibacterial agents |
| 04/29/2010 | US20100105606 Methods for making high oxygen affinity modified hemoglobin for oxygen transport |
| 04/29/2010 | US20100105605 Fatty acid formulations and oral delivery of proteins and peptides, and uses thereof |
| 04/29/2010 | US20100105604 Allyloxy and alkyloxy benzoic acid delivery agents |
| 04/29/2010 | US20100105603 Methods and Preparations For Curing Clinically Ill Patients |
| 04/29/2010 | US20100105602 Treatment of intracellular bacterial infections |
| 04/29/2010 | US20100105601 Method for treating a synucleinopathy |
| 04/29/2010 | US20100105121 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/29/2010 | US20100105077 Means for Detection and Purification of CD8+ T Lymphocyte Populations Specific to Peptides Presented in the Context of HLA |
| 04/29/2010 | US20100104664 Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods |
| 04/29/2010 | US20100104631 Method of treatment for bladder dysfunction |
| 04/29/2010 | US20100104629 Cationic lipids and uses thereof |
| 04/29/2010 | US20100104627 Stable aqueous g-csf formulations |
| 04/29/2010 | US20100104625 Biodegradable compositions and materials |
| 04/29/2010 | US20100104621 Treating adhd and other diseases involving inflammation |
| 04/29/2010 | US20100104607 Anti-bacterial peptides and methods of treating diseases using same |
| 04/29/2010 | US20100104599 Compositions and Methods For Enhancing Immune System of Felines |
| 04/29/2010 | US20100104592 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/29/2010 | US20100104587 Methods of modulating the negative chemotaxis of immune cells |
| 04/29/2010 | US20100104585 Methods and Reagents for Regulation of Cellular Responses in Biological Systems |
| 04/29/2010 | US20100104582 CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts |
| 04/29/2010 | US20100104580 Altered Immunogenic Landscape in HIV-1 Envelope Proteins |
| 04/29/2010 | US20100104579 Trex1 as a marker for lupus erythematosus |
| 04/29/2010 | US20100104576 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization; |
| 04/29/2010 | US20100104568 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders |
| 04/29/2010 | US20100104567 Pharmaceutical composition |
| 04/29/2010 | US20100104561 TYROSINE-MODIFIED RECOMBINANT rAAV VECTOR COMPOSITIONS AND METHODS FOR USE |
| 04/29/2010 | US20100104560 Botulinum neurotoxin e receptors and uses thereof |
| 04/29/2010 | US20100104559 Us cip-compositions and methods for modulating responses mediated or associated with btla activity |
| 04/29/2010 | US20100104555 HCV neutralizing epitopes |
| 04/29/2010 | US20100104554 Peptide and uses thereof |
| 04/29/2010 | US20100104552 Antibiotic synergism |
| 04/29/2010 | US20100104551 Method for prolonging activity of autodegradable enzymes and compositions thereof |
| 04/29/2010 | US20100104550 Cleavage of bip by subtilase cytotoxin |
| 04/29/2010 | US20100104549 Glufosfamide combination therapy |
| 04/29/2010 | US20100104548 Modulation of amino acid metabolism in the hypothalamus |
| 04/29/2010 | US20100104547 Topical composition for the treatment of allergenic effects |
| 04/29/2010 | US20100104545 Nutritional Composition To Promote Healthy Development And Growth |